Pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
We demonstrate that myeloid-specific loss of Phd2 resulted in an exaggerated inflammatory response to Streptococcus pneumonia, with increases in neutrophil motility, functional capacity, and survival.
|
28805660 |
2017 |
Pulmonary Fibrosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The mechanism may function through miR-210-mediated repression of RUNX3, which further decreases the hydroxylation activity of PHD2, enhances the stability of HIF-1α, and promotes PQ-induced EMT, aggravating the progression of pulmonary fibrosis.
|
28699703 |
2017 |
Renal fibrosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We concluded that the expression of PHD2 in endothelial cells plays a critical role in renal fibrosis and vascular remodelling in adult mice.
|
28266128 |
2017 |
Acute myocardial infarction
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we report the localized myocardial delivery of shRNA against PHD2 through ultrasound-targeted microbubble destruction (UTMD) for protection the heart from acute myocardial infarction.
|
28042316 |
2017 |
Malignant neoplasm of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We observed a significant association between the selected Tibetan EGLN1/PHD2 haplotype and lung cancer (p=0.0012 for D4E, p=0.0002 for C127S), corresponding to a two-fold increase in lung cancer risk.
|
28036300 |
2017 |
Exudative age-related macular degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
Gene transfer of PHD2 in vivo resulted in mitigation of HIF-mediated angiogenesis in a mouse model of nAMD.
|
28186209 |
2017 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
Different from EglN1 which function largely depends on the role of hypoxia-induce factor alpha (HIFα) in tumors, the functional significance and the upstream regulatory mechanisms of EglN2, especially in prostate cancer setting, remain largely unclear.
|
28089830 |
2017 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Different from EglN1 which function largely depends on the role of hypoxia-induce factor alpha (HIFα) in tumors, the functional significance and the upstream regulatory mechanisms of EglN2, especially in prostate cancer setting, remain largely unclear.
|
28089830 |
2017 |
Carcinoma of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We observed a significant association between the selected Tibetan EGLN1/PHD2 haplotype and lung cancer (p=0.0012 for D4E, p=0.0002 for C127S), corresponding to a two-fold increase in lung cancer risk.
|
28036300 |
2017 |
Primary malignant neoplasm of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We observed a significant association between the selected Tibetan EGLN1/PHD2 haplotype and lung cancer (p=0.0012 for D4E, p=0.0002 for C127S), corresponding to a two-fold increase in lung cancer risk.
|
28036300 |
2017 |
Liver regeneration disorder
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We sought to assess whether pharmacological inhibition of hypoxia-inducible transcription factor (HIF)-prolyl hydroxylase enzymes (PHD1, PHD2, and PHD3) is a suitable strategy to stimulate liver regeneration after partial hepatectomy for colorectal liver metastases (CRLM).
|
28266966 |
2017 |
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Of note, the expression of prolyl hydroxylase domain 2 (PHD2) is selectively increased in CKD-AT-MSCs and its inhibition can restore the expression of HIF-1α and the wound healing function of CKD-AT-MSCs.
|
28537846 |
2017 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
Biomarker
|
disease |
BEFREE |
The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.
|
28199842 |
2017 |
Septicemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Genetic variants in HIF-1α and PHD2 genes exist in Caucasians but do not appear to alter 30-day mortality in sepsis.
|
27515179 |
2016 |
Sepsis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Genetic variants in HIF-1α and PHD2 genes exist in Caucasians but do not appear to alter 30-day mortality in sepsis.
|
27515179 |
2016 |
Severe Sepsis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Thus, we tested the hypotheses, that SNPs in the HIF-1α or PHD2 genes are (1) common in Caucasians, with 2) the HIF-1α genetic variant being associated with an altered HIF-1α mRNA expression; and 3) independent risk factors for 30-day mortality in severe sepsis.
|
27515179 |
2016 |
KUFOR-RAKEB SYNDROME
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PHD2 inhibition was found to result in increased expression of ATP13A2, mutation of which is responsible for a rare juvenile form of PD known as Kufor-Rakeb syndrome.
|
26818499 |
2016 |
Respiratory Distress Syndrome, Adult
|
0.010 |
Biomarker
|
disease |
BEFREE |
Moreover, activation of HIF2α/VE-PTP signaling via PHD2 inhibition has the potential to prevent the formation of leaky vessels and edema in inflammatory diseases such as ARDS.
|
25574837 |
2015 |
Intervertebral Disc Degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
With respect to PHD2, the most abundant PHD isoform in NP cells, very little is known concerning its function and regulation under inflammatory conditions that characterize intervertebral disc degeneration.
|
25635047 |
2015 |
Acute Undifferentiated Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TRIM62 loss was associated with altered expression of proteins involved in leukemia stem cell homeostasis (β-catenin and Notch), cell motility, and adhesion (integrin-β3, ras-related C3 botulinum toxin substrate [RAC], and fibronectin), hypoxia (Hypoxia-inducible factor 1-alpha [HIF1α], egl-9 family hypoxia-inducible factor 1 [Egln1], and glucose-regulated protein, 78 kDa [GRP78]), and apoptosis (B-cell lymphoma-extra large (BclXL) and caspase 9).
|
25248926 |
2015 |
Undifferentiated leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TRIM62 loss was associated with altered expression of proteins involved in leukemia stem cell homeostasis (β-catenin and Notch), cell motility, and adhesion (integrin-β3, ras-related C3 botulinum toxin substrate [RAC], and fibronectin), hypoxia (Hypoxia-inducible factor 1-alpha [HIF1α], egl-9 family hypoxia-inducible factor 1 [Egln1], and glucose-regulated protein, 78 kDa [GRP78]), and apoptosis (B-cell lymphoma-extra large (BclXL) and caspase 9).
|
25248926 |
2015 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings show that PHD2 inhibits the adaptation of glioblastoma cells to hypoxia by regulating the HIF-α subunits in a non-canonical way.
|
25010988 |
2014 |
Prion Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In conclusion, our results indicate that gingerol has therapeutic potential for use in the treatment or prevention of prion diseases, and its inhibitory effects on the catalytic activity of PHD2 may be of clinical benefit.
|
25231392 |
2014 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings show that PHD2 inhibits the adaptation of glioblastoma cells to hypoxia by regulating the HIF-α subunits in a non-canonical way.
|
25010988 |
2014 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings show that PHD2 inhibits the adaptation of glioblastoma cells to hypoxia by regulating the HIF-α subunits in a non-canonical way.
|
25010988 |
2014 |